PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free drug delivery systems, today announced that it has hired Mr. Ralph Makar as President and Chief Executive Officer, effective October 1, 2007. “We are very fortunate to have such a seasoned pharmaceutical veteran join the Bioject team,” said Jerald S. Cobbs, Bioject’s Chairman. “Mr. Makar’s experience with specialty pharmaceuticals will add value to the Company, and help us implement a new direction and focus going forward. Our technology adds value to every injectable we deliver, and we look forward to working with strategic partners to demonstrate this added value by providing effective delivery systems to patients and professionals alike.”
